Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 101 PS2-14-09 | DOI: 10.1530/endoabs.101.PS2-14-09

ETA2024 Poster Presentations Clinical thyroid cancer research-2 (10 abstracts)

Predictive factors determining incomplete response to initial radioiodine therapy in patients with papillary thyroid microcarcinoma

Oumaima Zitoun 1 , Souhail Jbali 2 , Rim Brahem 2 , Amani Amri 2 , Taieb Ben Ghachem 3 , Alia Methneni 2 , Mohamed Dhaha 2 , Sawsen Dhambri 2 , Skander Kdous 2 & Aida Mhiri 3


1Salah Azaiz Institute, Otorhinolaryngology Department, Tunis, Tunisia; 2Salah Azaiz Institute, Otorhinolaryngology Departement, Tunis, Tunisia; 3Salah Azaiz Institute, Nuclear Medicine Department, Tunis, Tunisia


Objective: The aim of this study was to evaluate the response to initial postoperative radioactive iodine therapy (I-131) in patients with papillary thyroid microcarcinoma.

Methods: This was a retrospective study including 123 patients treated for papillary thyroid microcarcinoma with low to intermediate-risk, between 2012 and 2020. These patients underwent total thyroidectomy followed by radioactive iodine therapy (I-131). Clinical examination, thyroglobulin (Tg) levels measurement, ultrasound, and cervico-thoracic scintigraphy (CTS) were performed.

Results: The mean age was 44.4±14.1 years with a female predominance (86.2%). All patients received adjunctive I-131 therapy following total thyroidectomy. The most frequently observed tumor stage was T1aNx, accounting for 31.7% of tumors. Baseline Tg levels measurement and CTS were performed before the first treatment. Response assessment was performed at a median of 6 months following the first treatment. Based on clinical, biological, and radiological criteria, 95 patients (77.2%) were responders to treatment, while 28 patients (22.8%) were non-responders. Therapeutic response significantly varied according to baseline Tg levels and postoperative CTS results (P < 0.001). There was no statistically significant difference in response to the initial treatment regarding patients’ epidemiological, clinical, and therapeutic data.

Conclusion: Baseline Tg levels >10ng/ml, intense cervical uptake on postoperative CTS, and associated histological lesions are predictive factors of poor response to initial radioiodine therapy. Multicenter studies are warranted to establish a clear consensus regarding the strategy for adjunctive radioiodine therapy administration

Volume 101

46th Annual Meeting of the European Thyroid Association (ETA) 2024

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.